View upcoming earnings forecasts and in-depth analysis of company forecasts.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Oct 4 (Reuters) - GSK (GSK.L), opens new tab, Sanofi (SASY.PA), opens new tab and CSL Ltd (CSL.AX), opens new tab have secured $72 million from the U.S. government to ramp up production of bird ...

Divi’s Laboratories Limited specialises in producing active pharmaceutical ingredients and intermediates. The company is engaged in the manufacturing and custom synthesis of generic APIs and ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

as sentiments were lifted after the homegrown pharma company received regulatory approvals for acquisition of Bharat Serums and Vaccines Ltd. (BSV). The Competition Commission of India has cleared ...

Philip Dormitzer, GSK head of global vaccines research and development, said the company is “committed to finding innovative solutions that simplify immunisation against bacterial meningitis, support ...

Big Pharma is investing heavily in AI to slash development timelines and foster innovation. But instead of strengthening future relationships with the biotech world, the investment may position ...

This came after GlaxoSmithKline Pharmaceuticals presented protocol amendment 03 dated 25 June 2024 protocol no. 209628. Belantamab mafodotin is a monoclonal antibody conjugated with a cytotoxic agent ...

GSK’s Vi­iV Health­care has sus­pend­ed de­vel­op­ment of a Phase 2-stage HIV an­tivi­ral named VH3739937, a GSK spokesper­son con­firmed to End­points News on Tues­day.